Association of Human Leukocyte Antigen (HLA) Footprints with the Comorbidity of Latent Autoimmune Diabetes in Adults (LADA) and Hepatitis C Virus (HCV) Infection: A Multicenter Cross-Sectional Study
Yujin Ding,Pan Zhang,Tuo Deng,Xiang Yan,Min Zhang,Zhiguo Xie,Gan Huang,Ping Wang,Ting Cai,Xiaoli Zhang,Xinqiang Xiao,Ying Xia,Bingwen Liu,Ya Peng,Xiaohan Tang,Min Hu,Yang Xiao,Xia Li,Erik De Clercq,Guangdi Li,Zhiguang Zhou
DOI: https://doi.org/10.1016/j.dsx.2023.102939
2023-01-01
Diabetes & Metabolic Syndrome Clinical Research & Reviews
Abstract:Aims: This study aims to investigate the interplay between hepatitis C virus (HCV) infection and major forms of diabetes: type 1 diabetes (T1D), type 2 diabetes (T2D), and latent autoimmune diabetes in adults (LADA). Methods: This multicenter study analyzed a cohort of 2699 diabetic and 7344 non-diabetic subjects who visited medical centers in China from 2014 to 2021. T1D, T2D, LADA, and HCV were diagnosed using standard procedures. High-throughput sequencing was conducted to identify genetic footprints of human leukocyte antigen (HLA) alleles and haplotypes at the DRB1, DQA1, and DQB1 loci. Results: HCV infection was detected in 3 % (23/766) of LADA patients, followed by 1.5 % (15/977) of T2D patients, 1.4 % (13/926) of T1D patients, and 0.5 % (38/7344) of non-diabetic individuals. HCV prevalence was significantly higher in people with diabetes than in non-diabetic individuals (p < 0.01). HLA alleles (DQB1*060101, DQB1*040101) and haplotypes (DRB1*080302-DQA1*010301-DQB1*060101) in LADA patients with HCV revealed higher frequencies than in LADA patients without HCV (adjusted p < 0.03). Furthermore, a higher risk of diabetes complications was found among LADA patients with HCV infection (p < 0.001). Conclusions: LADA patients are susceptible to HCV infection, potentially associated with certain HLA alleles/haplotypes. Early diagnosis and treatment of HCV infection among people with diabetes are important for the management of severe complications.